CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $959,017 | -18.6% | 34,848 | +0.3% | 0.01% | -20.0% |
| Q2 2023 | $1,178,559 | +5.3% | 34,735 | +11.7% | 0.01% | 0.0% |
| Q1 2023 | $1,119,158 | -21.4% | 31,105 | -2.6% | 0.01% | -23.1% |
| Q4 2022 | $1,423,967 | +98.3% | 31,949 | +25.0% | 0.01% | +85.7% |
| Q3 2022 | $718,000 | -4.0% | 25,560 | -7.9% | 0.01% | 0.0% |
| Q2 2022 | $748,000 | -49.3% | 27,740 | -61.2% | 0.01% | -50.0% |
| Q1 2021 | $1,475,000 | +19.0% | 71,581 | +1.2% | 0.01% | 0.0% |
| Q4 2020 | $1,239,000 | – | 70,720 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |